node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ANK1 | CCDC8 | ENSP00000265709 | ENSP00000303158 | ankyrin 1, erythrocytic | coiled-coil domain containing 8 | 0.509 |
ANK1 | KCTD21 | ENSP00000265709 | ENSP00000339340 | ankyrin 1, erythrocytic | potassium channel tetramerisation domain containing 21 | 0.540 |
ANK1 | KCTD5 | ENSP00000265709 | ENSP00000301738 | ankyrin 1, erythrocytic | potassium channel tetramerisation domain containing 5; Its interaction with CUL3 suggests that it may act as a substrate adapter in some E3 ligase complex. Does not affect the function of Kv channel Kv2.1/KCNB1, Kv1.2/KCNA2, Kv4.2/KCND2 and Kv3.4/KCNC4 | 0.409 |
CCDC8 | ANK1 | ENSP00000303158 | ENSP00000265709 | coiled-coil domain containing 8 | ankyrin 1, erythrocytic | 0.509 |
CCDC8 | FBXW8 | ENSP00000303158 | ENSP00000310686 | coiled-coil domain containing 8 | F-box and WD repeat domain containing 8; Substrate-recognition component of a SCF-like E3 ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. In complex with CUL7, mediates ubiquitination and consequent degradation of GORASP1, acting as a component of the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain | 0.680 |
CCDC8 | KAT5 | ENSP00000303158 | ENSP00000340330 | coiled-coil domain containing 8 | K(lysine) acetyltransferase 5 | 0.913 |
CCDC8 | KCTD2 | ENSP00000303158 | ENSP00000312814 | coiled-coil domain containing 8 | potassium channel tetramerisation domain containing 2 | 0.543 |
CCDC8 | KCTD21 | ENSP00000303158 | ENSP00000339340 | coiled-coil domain containing 8 | potassium channel tetramerisation domain containing 21 | 0.607 |
CCDC8 | KCTD5 | ENSP00000303158 | ENSP00000301738 | coiled-coil domain containing 8 | potassium channel tetramerisation domain containing 5; Its interaction with CUL3 suggests that it may act as a substrate adapter in some E3 ligase complex. Does not affect the function of Kv channel Kv2.1/KCNB1, Kv1.2/KCNA2, Kv4.2/KCND2 and Kv3.4/KCNC4 | 0.577 |
CCDC8 | MAPK14 | ENSP00000303158 | ENSP00000229794 | coiled-coil domain containing 8 | mitogen-activated protein kinase 14; Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are a [...] | 0.911 |
CCDC8 | OBSL1 | ENSP00000303158 | ENSP00000385636 | coiled-coil domain containing 8 | obscurin-like 1; Regulates CUL7-FBXW8-containing ubiquitin ligase complex, playing a critical role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain. Localizes CUL7 to the Golgi apparatus in neurons | 0.905 |
CCDC8 | SSH3 | ENSP00000303158 | ENSP00000312081 | coiled-coil domain containing 8 | slingshot homolog 3 (Drosophila); Protein phosphatase which may play a role in the regulation of actin filament dynamics. Can dephosphorylate and activate the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly (By similarity) | 0.529 |
CCDC8 | TP53 | ENSP00000303158 | ENSP00000269305 | coiled-coil domain containing 8 | tumor protein p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (By similarity) | 0.944 |
FBXW8 | CCDC8 | ENSP00000310686 | ENSP00000303158 | F-box and WD repeat domain containing 8; Substrate-recognition component of a SCF-like E3 ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. In complex with CUL7, mediates ubiquitination and consequent degradation of GORASP1, acting as a component of the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain | coiled-coil domain containing 8 | 0.680 |
FBXW8 | OBSL1 | ENSP00000310686 | ENSP00000385636 | F-box and WD repeat domain containing 8; Substrate-recognition component of a SCF-like E3 ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. In complex with CUL7, mediates ubiquitination and consequent degradation of GORASP1, acting as a component of the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain | obscurin-like 1; Regulates CUL7-FBXW8-containing ubiquitin ligase complex, playing a critical role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain. Localizes CUL7 to the Golgi apparatus in neurons | 0.742 |
FBXW8 | TP53 | ENSP00000310686 | ENSP00000269305 | F-box and WD repeat domain containing 8; Substrate-recognition component of a SCF-like E3 ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. In complex with CUL7, mediates ubiquitination and consequent degradation of GORASP1, acting as a component of the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain | tumor protein p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (By similarity) | 0.886 |
KAT5 | CCDC8 | ENSP00000340330 | ENSP00000303158 | K(lysine) acetyltransferase 5 | coiled-coil domain containing 8 | 0.913 |
KAT5 | TP53 | ENSP00000340330 | ENSP00000269305 | K(lysine) acetyltransferase 5 | tumor protein p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (By similarity) | 0.999 |
KCTD2 | CCDC8 | ENSP00000312814 | ENSP00000303158 | potassium channel tetramerisation domain containing 2 | coiled-coil domain containing 8 | 0.543 |
KCTD21 | ANK1 | ENSP00000339340 | ENSP00000265709 | potassium channel tetramerisation domain containing 21 | ankyrin 1, erythrocytic | 0.540 |